These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7209991)

  • 1. The interface of toxicology and tissue culture and reflections on the carnation test.
    Nardone RM
    Toxicology; 1980; 17(2):105-11. PubMed ID: 7209991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of batteries of short-term tests for carcinogens.
    Tweats DJ
    Food Addit Contam; 1984; 1(2):189-97. PubMed ID: 6536530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of toxic compounds in tissue culture.
    Ekwall B
    Toxicology; 1980; 17(2):127-42. PubMed ID: 7209994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
    Benigni R
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro techniques: can they replace animal testing?
    Pearson RM
    Hum Reprod; 1986 Dec; 1(8):559-60. PubMed ID: 3818914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenicity research and testing in Sweden.
    Ramel C
    Mutat Res; 1975 Nov; 33(1 Spec No):79-86. PubMed ID: 1202342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic toxicology.
    Food Cosmet Toxicol; 1980 Dec; 18(6):683-709. PubMed ID: 7203312
    [No Abstract]   [Full Text] [Related]  

  • 13. The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Lee WR; Abrahamson S; Valencia R; von Halle ES; Würgler FE; Zimmering S
    Mutat Res; 1983 Oct; 123(2):183-279. PubMed ID: 6413857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations at the interface of mutation research and regulatory policy.
    Flamm WG
    Mutat Res; 2003 Sep; 544(1):1-7. PubMed ID: 12888105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
    Silva Lima B; Van der Laan JW
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):135-43. PubMed ID: 11067770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological barriers to providing better drugs.
    Lasagna L
    Arch Toxicol; 1979 Oct; 43(1):27-33. PubMed ID: 533359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic-sensitive mutants of Saccharomyces cerevisiae as screening organisms for promutagens and procarcinogens.
    Morita T; Yanagihara Y
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1576-82. PubMed ID: 3899386
    [No Abstract]   [Full Text] [Related]  

  • 19. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.